Social Media Ideas for Drugs For Neglected Diseases Initiative

FFAR, Notre Dame investing in New World screwworm drug research

Studies have shown that nitisinone kills several blood-feeding ​arthropods by blocking a key enzyme they need to digest blood.

Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M deal

Dimerix has bought an acute kidney injury drug from Mission Therapeutics, paying $5 million upfront and committing up to $287 million in milestones for the phase 2-ready asset.

AGC and Neusignal Therapeutics Collaborate on the Development of Alzheimer's Disease Drug Candidate “NTX-083”

AGC Inc. (Headquarters: Tokyo; President: Yoshinori Hirai; hereinafter “AGC”) highlights its end-to-end support capabilities as a small-molecule pharmaceutical CDMO as demonstrated...

Takeda aims for dengue vaccine inclusion in India's shots program

Genome Mining Points to Less Toxic, More Potent Polyene Antifungals in Mice

The researchers identified Nys34 as a leading candidate after it demonstrated three-to-eightfold lower toxicity than amphotericin B in multiple human cell lines and reduced fungal...

With $263M, LifeMine unearths a new drug for organ transplants

Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...

Senegal-made sickle cell treatment raises hopes, reduces costs

Mamadou Tahirou is 18 but looks more like a 12-year-old. His frame is frail from the ravages of sickle cell disease, which one Senegalese laboratory hopes to attenuate with afforda...

New Era of HIV Drugs

Simpler drug regimens could improve adherence to treatment. The post New Era of HIV Drugs appeared first on The Good Men Project.

EXCLUSIVE: Drug companies choosing not to sell life-saving and life-extending medicines in Canada

When Ruchi Ambike found out that Novartis got Health Canada approval for Vanrafia she was ecstatic. The drug can possibly slow down the progression of her Immunoglobulin gA nephrop...

DOW, NIH Ink Agreement to Advance Medical Countermeasures Development

DOW and NIH have signed an agreement to advance medical countermeasures against CBRN threats and emerging infectious diseases. The post DOW, NIH Ink Agreement to Advance Medical Co...

With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access

Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But access to the drug and other new products in much of L...

Non-Profit Pharmaceutical Manufacturer Delivers Drug Access to Rural Hospitals

<![CDATA[BioMarin and n-Lorem Foundation Enter Research Collaboration for ReNU Syndrome Treatment ]]>

Rare Disease Hunger Games

Rare Disease Hunger Games Anonymous (not verified) Mon, 08/24/2026 - 06:39 field_thread_url https://cafepharma.com/boards/threads/rare-disease-hunger-games...

<![CDATA[FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma]]>

<![CDATA[Pharmaceutical Executive Daily: BioMarin and n-Lorem Foundation Enter Collaboration]]>

Rare Disease Hunger Games

Rare Disease Hunger Games Anonymous (not verified) Sun, 08/16/2026 - 03:35 field_thread_url https://cafepharma.com/boards/threads/rare-disease-hunger-games...

Early Genomic Indicators of Praziquantel Resistance in Schistosoma mansoni

Schistosomiasis affects more than 250 million people worldwide, with 90% of infections occurring in sub‑Saharan Africa. The post Early Genomic Indicators of Praziquantel Resistance...

Rewriting Disease: Oligonucleotides Take Aim at the Untreatable

How synthetic DNA and RNA are becoming the discovery engines behind a new generation of precision therapies. The post Rewriting Disease: Oligonucleotides Take Aim at the Untreatabl...

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.

Inaugural AACR D3 Opens With Insights From Leaders Across Drug Discovery and Development

During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO, PhD (hc), FAACR; Keith T. Flaherty MD, FAACR;...

<![CDATA[The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan]]>

Senegalese company produces first Africa-made treatment for sickle cell disease

Africa accounts for nearly 80 per cent of cases of the inherited red blood cell disorder but has relied on expensive imported medication.

Rwanda: Rwanda Rolls Out Five-Year Strategy to Fight NCDs

[New Times] Rwanda is targeting the interruption of transmission of leprosy and onchocerciasis (river blindness) by 2030, under a new five-year plan to tackle neglected tropical di...